MedinCell S.A. (MDCLF) Q2 2026 Earnings Call Transcript
Source: SeekingAlpha
2025-12-09 15:17:08 ET
MedinCell S.A. (MDCLF) Q2 2026 Earnings Call December 9, 2025 1:00 PM EST
Company Participants
David Heuzé - Head of Corporate & Financial Communications and ESG
Christophe Douat - Chief Executive Officer & Director
Richard Malamut - Chief Medical Officer
Stephane Postic - Chief Financial Officer
...
Read the full article on Seeking Alpha
For further details see:
MedinCell S.A. (MDCLF) Q2 2026 Earnings Call Transcript
Medical Intelligence Technologies Inc
NASDAQ: MDCLF
MDCLF Trading
100.0% G/L:
$6.9757 Last:
2,000 Volume:
$0 Open:
MDCLF Latest News
November 11, 2025 02:00:00 am
Medincell Appoints Dr Grace Kim, Chief Strategy Officer, U.S. Finance, to Advance into Next Stage of US Capital Growth
November 10, 2025 12:00:00 pm
Medincell to Join MSCI World Small Cap Index, a Leading Global Benchmark
February 10, 2025 02:00:00 am
Completion of the Pivotal Phase 3 Trial for Olanzapine LAI in Schizophrenia Conducted by Teva Pharmaceuticals
